Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome
- PMID: 14633867
- PMCID: PMC7108161
- DOI: 10.1373/clinchem.2003.024125
Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome
Abstract
Background: The availability of an early diagnostic tool for severe acute respiratory syndrome (SARS) would have major public health implications. We investigated whether the SARS coronavirus (SARS-CoV) can be detected in serum and plasma samples during the early stages of SARS and studied the potential prognostic implications of such an approach.
Methods: We developed two real-time quantitative reverse transcription-PCR (RT-PCR) assays, one for the polymerase and the other for the nucleocapsid region of the virus genome, for measuring the concentration of SARS-CoV RNA in serum/plasma samples from SARS patients. Plasma samples were obtained from 12 confirmed SARS patients on the day of hospital admission, as well as on days 7 and 14 after fever onset. Serum samples were also obtained from 23 confirmed SARS patients on the day of hospital admission, 11 of whom subsequently required intensive care. Viral RNA was extracted from the plasma/serum samples. The extracted RNA was subjected to analysis by the RT-PCR assays.
Results: The RT-PCR system for the polymerase region detected SARS-CoV RNA in 50% of plasma and 78% of serum samples from SARS patients during the first week of illness. The detection rates for plasma dropped to 25% at day 14 after fever onset. The median serum SARS-CoV concentrations in patients who required and did not require intensive care unit admission during the course of hospitalization were 5800 and 140 copies/mL, respectively (Mann-Whitney test, P <0.005). These data were confirmed by the RT-PCR system for the nucleocapsid region, which showed an even higher detection rate of 87%. The correlation between the results obtained by the two RT-PCR systems was high (Pearson correlation analysis, r = 0.998; P <0.001).
Conclusion: Plasma/serum SARS-CoV quantification represents a potentially useful early diagnostic and prognostic tool for SARS.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7108161/bin/cy1234554001.gif)
Similar articles
-
Molecular diagnosis of severe acute respiratory syndrome.Methods Mol Biol. 2006;336:163-75. doi: 10.1385/1-59745-074-X:163. Methods Mol Biol. 2006. PMID: 16916262 Free PMC article.
-
[Detection of SARS coronavirus RNA].Nihon Rinsho. 2005 Dec;63 Suppl 12:366-71. Nihon Rinsho. 2005. PMID: 16416820 Review. Japanese. No abstract available.
-
Molecular diagnosis of severe acute respiratory syndrome: the state of the art.J Mol Diagn. 2005 Nov;7(5):551-9. doi: 10.1016/S1525-1578(10)60587-9. J Mol Diagn. 2005. PMID: 16258152 Free PMC article. Review.
-
Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus.J Clin Microbiol. 2004 May;42(5):2043-7. doi: 10.1128/JCM.42.5.2043-2047.2004. J Clin Microbiol. 2004. PMID: 15131168 Free PMC article.
-
Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays.Clin Chem. 2004 Jan;50(1):67-72. doi: 10.1373/clinchem.2003.023663. Clin Chem. 2004. PMID: 14709637 Free PMC article.
Cited by
-
Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies.Pathogens. 2023 Jul 5;12(7):911. doi: 10.3390/pathogens12070911. Pathogens. 2023. PMID: 37513758 Free PMC article. Review.
-
SARS-CoV-2 viremia and COVID-19 mortality: A prospective observational study.PLoS One. 2023 Apr 28;18(4):e0281052. doi: 10.1371/journal.pone.0281052. eCollection 2023. PLoS One. 2023. PMID: 37115764 Free PMC article.
-
Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma.J Clin Invest. 2022 Sep 1;132(17):e159876. doi: 10.1172/JCI159876. J Clin Invest. 2022. PMID: 35834347 Free PMC article.
-
The Pre-Vaccination Donated Blood Is Free from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) but Is Rich with Anti-SARS-CoV-2 Antibodies: A Cross-Section Saudi Study.Int J Environ Res Public Health. 2022 Jun 10;19(12):7119. doi: 10.3390/ijerph19127119. Int J Environ Res Public Health. 2022. PMID: 35742368 Free PMC article.
-
Coronavirus Disease 2019 (COVID-19): Emerging detection technologies and auxiliary analysis.J Clin Lab Anal. 2022 Jan;36(1):e24152. doi: 10.1002/jcla.24152. Epub 2021 Dec 10. J Clin Lab Anal. 2022. PMID: 34894011 Free PMC article. Review.
References
-
- Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-1976. - PubMed
-
- Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-1966. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous